본문 바로가기

Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
NEURAL REGENERATION RESEARCH17(7) · pp.1556 · 2022
피인용
Web of Science 14Scopus 14
FWCI (Scopus)
0.91
JCR IF
JCR 2021 6.058
ISSN
1673-5374

저자

  1. 이홍주제1저자Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
  2. 정다희Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
  3. 김남권Pusan Natl Univ, Sch Korean Med, Dept Korean Ophthalmol Otolaryngol Ana Dermatol, Yangsan, South Korea
  4. 신화경Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea
  5. 최병태교신저자Pusan Natl Univ, Sch Korean Med, Dept Korean Mec Sci, Yangsan, South Korea

초록

© 2022 Wolters Kluwer Medknow Publications. All rights reserved.Neural/glial antigen 2 (NG2)-expressing cells has multipotent stem cell activity under cerebral ischemia. Our study examined the effects of electroacupuncture (EA) therapy (2 Hz, 1 or 3 mA, 20 minutes) at the Sishencong acupoint on motor function after ischemic insult in the brain by investigating the rehabilitative potential of NG2-derived cells in a mouse model of ischemic stroke. EA stimulation alleviated motor deficits caused by ischemic stroke, and 1 mA EA stimulation was more efficacious than 3 mA EA stimulation or positive control treatment with edaravone, a free radical scavenger. The properties of NG2-expressing cells were altered with 1 mA EA stimulation, enhancing their survival in perilesional brain tissue via reduction of tumor necrosis factor alpha expression. EA stimulation robustly activated signaling pathways related to proliferation and survival of NG2-expressing cells and increased the expression of neurotrophic factors such as brain-derived neurotrophic factor, tumor growth factor beta, and neurotrophin 3. In the perilesional striatum, EA stimulation greatly increased the number of NG2-expressing cells double-positive for oligodendrocyte, endothelial cell, and microglia/macrophage markers (CC1, CD31, and CD68). EA therapy also greatly activated brain-derived neurotrophic factor/tropomyosin receptor kinase B and glycogen synthase kinase 3 beta signaling. Our results indicate that EA therapy may prevent functional loss at the perilesional site by enhancing survival and differentiation of NG2-expressing cells via the activation of brain-derived neurotrophic factor -induced signaling, subsequently ameliorating motor dysfunction. The animal experiments were approved by the Animal Ethics Committee of Pusan National University (approval Nos. PNU2019-2199 and PNU2019-2884) on April 8, 2019 and June 19, 2019.

키워드

Brain-derived neurotrophic factorDifferentiationElectroacupunctureMotor functionNeural/glial antigen 2Perilesional striatumStrokeSurvivalNG2 PROTEOGLYCANWHITE-MATTERRAT-BRAINEXPRESSIONDIFFERENTIATIONPROLIFERATIONNEUROTROPHINSACUPUNCTUREMACROPHAGESPROGENITORS

식별자

Scopus EID
2-s2.0-85122013011
WoS UID
000766430900033